Analytical Data
-
Gene name
RTL1
- Application
-
Alternative Names
PEG11; MART1; MAR1; Mammalian retrotransposon derived protein 1; Paternally expressed gene 11 protein; Retrotransposon-derived protein PEG11
-
Species
Mouse
-
Source
E. coli
-
Tag
Two N- s, His- & SUMO-
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7M732
-
Expression Region
Asn296~Glu416
-
Molecular Weight
38kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RTL1 (Retrotransposon-like 1) is an intriguing gene that has garnered significant attention in recent years, primarily due to its role in cellular functions and its implications in various diseases. Initially identified as a member of the retrotransposon family, RTL1 is believed to play a crucial role in embryonic development and the regulation of gene expression. Studies have shown that RTL1 is involved in the epigenetic landscape, influencing processes such as genomic imprinting, which is essential for normal development and cellular differentiation. Alterations or dysregulation of RTL1 expression have been linked to several pathological conditions, including cancer and neurological disorders, making it a focal point for research aimed at understanding the underlying mechanisms of these diseases. Furthermore, RTL1's potential as a biomarker for certain conditions has led to increased interest in unraveling its exact functions and pathways. The recombinant protein studies of RTL1 have opened up new avenues for therapeutic interventions and have highlighted its significance in both basic and applied biological research, paving the way for future investigations into gene therapy and regenerative medicine. Thus, the exploration of RTL1 and its recombinant protein not only enhances our comprehension of genetic regulation but also holds promise for innovative treatment strategies in various health conditions.
